{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:49:30Z","timestamp":1788569370754,"version":"build-2803163510"},"reference-count":30,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.2967\/jnumed.118.210997","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T16:35:14Z","timestamp":1526661314000},"page":"60-64","source":"Crossref","is-referenced-by-count":96,"title":["Feasibility of CXCR4-Directed Radioligand Therapy in Advanced Diffuse Large B-Cell Lymphoma"],"prefix":"10.2967","volume":"60","author":[{"given":"Constantin","family":"Lapa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"H\u00e4nscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schirbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Wunderlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Samnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Kotzerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"Wester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6tz Ulrich","family":"Grigoleit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2018,5,18]]},"reference":[{"key":"2021051712125047000_60.1.60.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"2021051712125047000_60.1.60.2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.137"},{"key":"2021051712125047000_60.1.60.3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-185827"},{"key":"2021051712125047000_60.1.60.4","doi-asserted-by":"publisher","DOI":"10.1002\/path.4446"},{"key":"2021051712125047000_60.1.60.5","doi-asserted-by":"publisher","DOI":"10.7150\/thno.11251"},{"key":"2021051712125047000_60.1.60.6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-15-0987"},{"key":"2021051712125047000_60.1.60.7","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201100320"},{"key":"2021051712125047000_60.1.60.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.098798"},{"key":"2021051712125047000_60.1.60.9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.7150\/thno.13986","article-title":"68Ga-pentixafor-PET\/CT for imaging of chemokine receptor 4 expression in glioblastoma","volume":"6","author":"Lapa","year":"2016","journal-title":"Theranostics."},{"key":"2021051712125047000_60.1.60.10","doi-asserted-by":"crossref","first-page":"9288","DOI":"10.18632\/oncotarget.7063","article-title":"[68Ga]pentixafor-PET\/CT for imaging of chemokine receptor 4 expression in small cell lung cancer: initial experience","volume":"7","author":"Lapa","year":"2016","journal-title":"Oncotarget."},{"key":"2021051712125047000_60.1.60.11","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.161034"},{"key":"2021051712125047000_60.1.60.12","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404698"},{"key":"2021051712125047000_60.1.60.13","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1097\/RLU.0000000000001435","article-title":"Investigating the chemokine receptor 4 as potential theranostic target in adrenocortical cancer patients","volume":"42","author":"Bluemel","year":"2017","journal-title":"Clin Nucl Med."},{"key":"2021051712125047000_60.1.60.14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7150\/thno.16576","article-title":"[68Ga]pentixafor-PET\/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma: comparison to [18F]FDG and laboratory values","volume":"7","author":"Lapa","year":"2017","journal-title":"Theranostics."},{"key":"2021051712125047000_60.1.60.15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.7150\/thno.18754","article-title":"Imaging of chemokine receptor 4 expression in neuroendocrine tumors: a triple tracer comparative approach","volume":"7","author":"Werner","year":"2017","journal-title":"Theranostics."},{"key":"2021051712125047000_60.1.60.16","doi-asserted-by":"crossref","first-page":"96732","DOI":"10.18632\/oncotarget.18235","article-title":"Targeting CXCR4 with [68Ga]pentixafor: a suitable theranostic approach in pleural mesothelioma?","volume":"8","author":"Lapa","year":"2017","journal-title":"Oncotarget."},{"key":"2021051712125047000_60.1.60.17","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1756"},{"key":"2021051712125047000_60.1.60.18","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.7150\/thno.19119","article-title":"[177Lu]pentixather: comprehensive preclinical characterization of a first CXCR4-directed endoradiotherapeutic agent","volume":"7","author":"Schottelius","year":"2017","journal-title":"Theranostics."},{"key":"2021051712125047000_60.1.60.19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7150\/thno.21397","article-title":"Dual targeting of acute leukemia and supporting niche by CXCR4-directed theranostics","volume":"8","author":"Habringer","year":"2018","journal-title":"Theranostics."},{"key":"2021051712125047000_60.1.60.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.167361"},{"key":"2021051712125047000_60.1.60.21","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.7150\/thno.19050","article-title":"CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed multiple myeloma","volume":"7","author":"Lapa","year":"2017","journal-title":"Theranostics."},{"key":"2021051712125047000_60.1.60.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2330-6"},{"key":"2021051712125047000_60.1.60.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05663.x"},{"key":"2021051712125047000_60.1.60.24","unstructured":"Welcome to MedDRA. Medical Dictionary for Regulatory Activities website. https:\/\/www.meddra.org\/. Accessed September 5, 2018."},{"key":"2021051712125047000_60.1.60.25","unstructured":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE). Cancer Therapy Evaluation Program website. http:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcaev3.pdf. Published August 9, 2006. Accessed September 5, 2018."},{"key":"2021051712125047000_60.1.60.26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"2021051712125047000_60.1.60.27","doi-asserted-by":"crossref","unstructured":"Lapa C Luckerath K Kircher S . Potential influence of concomitant chemotherapy on CXCR4 expression in receptor directed endoradiotherapy. Br J Haematol. January 24, 2018 [Epub ahead of print].","DOI":"10.1111\/bjh.15096"},{"key":"2021051712125047000_60.1.60.28","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00259-017-3657-9","article-title":"213Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer","volume":"44","author":"Sathekge","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712125047000_60.1.60.29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.191395"},{"key":"2021051712125047000_60.1.60.30","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.203539"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.210997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T16:31:28Z","timestamp":1621269088000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.210997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,18]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,2]]},"published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.2967\/jnumed.118.210997"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.210997","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,18]]}}}